Press releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 23, 2025
"This was another excellent quarter, marked by exceptional top-line performance,” said chairman and CEO Mike Mahoney
-
Jul 7, 2025
The FARAPULSE PFA System now approved for pulmonary vein and posterior wall ablation in patients with persistent atrial fibrillation
-
Jul 1, 2025
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the second quarter ended June 30, 2025, on Wednesday, July 23,...
-
May 1, 2025
Boston Scientific will participate in two upcoming investor conferences in May 2025. A live webcast and replay will be available for each event. Read more.
Apr 24, 2025Trial achieves positive results in the treatment of persistent atrial fibrillation.